European Commission 12 February 2021, Commission Implementing Decision (EU) 2021/184 of 12 February 2021 amending Decisions 2009/813/EC, 2009/814/EC and 2010/429/EU and Implementing Decisions 2012/82/EU, 2012/83/EU, 2012/347/EU, 2013/649/EU, (EU) 2015/683, (EU) 2015/684, (EU) 2015/685, (EU) 2015/686, (EU) 2015/687, (EU) 2015/688, (EU) 2015/689, (EU) 2015/693, (EU) 2015/695, (EU) 2015/696, (EU) 2015/700, (EU) 2015/701, (EU) 2015/2279, (EU) 2015/2281, (EU) 2016/1216, (EU) 2016/1217, (EU) 2017/1207, (EU) 2018/1111, (EU) 2018/2045, (EU) 2018/2046, (EU) 2019/1307, (EU) 2019/1308, (EU) 2019/1309, (EU) 2019/2083 and (EU) 2020/1360 as regards the authorisation holder and its representative in the Union for the placing on the market of products containing, consisting of or produced from certain genetically modified organisms (notified under document C(2021) 826) (Only the Dutch text is authentic) (Text with EEA relevance)

Also known as

Commission Implementing Decision (EU) 2021/184 of 12 February 2021 amends 32 prior authorisation decisions issued under Regulation (EC) No 1829/2003 concerning genetically modified food and feed, solely to reflect the administrative change whereby Bayer Agriculture BVBA (Belgium) was renamed Bayer Agriculture BV and Monsanto Company (United States) converted its legal form and changed its name to Bayer CropScience LP, both effective 1 August 2020. The amendments update the authorisation holder, addressee, and annex provisions in each affected decision to substitute the new entity names and confirm Bayer Agriculture BV as the Union representative of Bayer CropScience LP. The Decision is addressed to Bayer Agriculture BV, Scheldelaan 460, 2040 Antwerp, Belgium, and was adopted without a new scientific assessment of the products concerned.AI